Cargando…
The Brugada syndrome: risk stratification
Thirty years after its first description, the knowledge regarding Brugada syndrome has greatly increased. Spontaneous type 1 ECG pattern (BrECG) is a well-defined prognostic marker in asymptomatic patients and is associated with a double risk of arrhythmic events during follow-up as compared to drug...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132603/ https://www.ncbi.nlm.nih.gov/pubmed/37125275 http://dx.doi.org/10.1093/eurheartjsupp/suad035 |
_version_ | 1785031418289586176 |
---|---|
author | Gaita, Fiorenzo Cerrato, Natascia Saglietto, Andrea Caponi, Domenico Calò, Leonardo Giustetto, Carla |
author_facet | Gaita, Fiorenzo Cerrato, Natascia Saglietto, Andrea Caponi, Domenico Calò, Leonardo Giustetto, Carla |
author_sort | Gaita, Fiorenzo |
collection | PubMed |
description | Thirty years after its first description, the knowledge regarding Brugada syndrome has greatly increased. Spontaneous type 1 ECG pattern (BrECG) is a well-defined prognostic marker in asymptomatic patients and is associated with a double risk of arrhythmic events during follow-up as compared to drug-induced ECG pattern. Due to the extreme variability of the ECG pattern over time, the spontaneous type 1 BrECG must be carefully sought, not only through periodic ECGs but especially with repeated 12-lead 24-h Holter monitoring, with V1 and V2 electrodes placed also on the second and third intercostal space, in order to explore the right ventricular outflow tract. 12-lead 24-h Holter should also be performed in all the patients with a dubious BrECG pattern even before the drug challenge with sodium channel blockers, which carries a low but definite risk of complications. In addition to spontaneous type 1, other electrocardiographic markers of increased arrhythmic risk have been described, such as first-degree AV block, QRS fragmentation, S wave in lead I and II, and increased QRS duration. The electrophysiological study in asymptomatic patients with a spontaneous ECG Brugada pattern is still under jury and further studies need to clarify its precise role. |
format | Online Article Text |
id | pubmed-10132603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101326032023-04-27 The Brugada syndrome: risk stratification Gaita, Fiorenzo Cerrato, Natascia Saglietto, Andrea Caponi, Domenico Calò, Leonardo Giustetto, Carla Eur Heart J Suppl PLACE 2022 Supplement Paper Thirty years after its first description, the knowledge regarding Brugada syndrome has greatly increased. Spontaneous type 1 ECG pattern (BrECG) is a well-defined prognostic marker in asymptomatic patients and is associated with a double risk of arrhythmic events during follow-up as compared to drug-induced ECG pattern. Due to the extreme variability of the ECG pattern over time, the spontaneous type 1 BrECG must be carefully sought, not only through periodic ECGs but especially with repeated 12-lead 24-h Holter monitoring, with V1 and V2 electrodes placed also on the second and third intercostal space, in order to explore the right ventricular outflow tract. 12-lead 24-h Holter should also be performed in all the patients with a dubious BrECG pattern even before the drug challenge with sodium channel blockers, which carries a low but definite risk of complications. In addition to spontaneous type 1, other electrocardiographic markers of increased arrhythmic risk have been described, such as first-degree AV block, QRS fragmentation, S wave in lead I and II, and increased QRS duration. The electrophysiological study in asymptomatic patients with a spontaneous ECG Brugada pattern is still under jury and further studies need to clarify its precise role. Oxford University Press 2023-04-26 /pmc/articles/PMC10132603/ /pubmed/37125275 http://dx.doi.org/10.1093/eurheartjsupp/suad035 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | PLACE 2022 Supplement Paper Gaita, Fiorenzo Cerrato, Natascia Saglietto, Andrea Caponi, Domenico Calò, Leonardo Giustetto, Carla The Brugada syndrome: risk stratification |
title | The Brugada syndrome: risk stratification |
title_full | The Brugada syndrome: risk stratification |
title_fullStr | The Brugada syndrome: risk stratification |
title_full_unstemmed | The Brugada syndrome: risk stratification |
title_short | The Brugada syndrome: risk stratification |
title_sort | brugada syndrome: risk stratification |
topic | PLACE 2022 Supplement Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132603/ https://www.ncbi.nlm.nih.gov/pubmed/37125275 http://dx.doi.org/10.1093/eurheartjsupp/suad035 |
work_keys_str_mv | AT gaitafiorenzo thebrugadasyndromeriskstratification AT cerratonatascia thebrugadasyndromeriskstratification AT sagliettoandrea thebrugadasyndromeriskstratification AT caponidomenico thebrugadasyndromeriskstratification AT caloleonardo thebrugadasyndromeriskstratification AT giustettocarla thebrugadasyndromeriskstratification AT gaitafiorenzo brugadasyndromeriskstratification AT cerratonatascia brugadasyndromeriskstratification AT sagliettoandrea brugadasyndromeriskstratification AT caponidomenico brugadasyndromeriskstratification AT caloleonardo brugadasyndromeriskstratification AT giustettocarla brugadasyndromeriskstratification |